Search

Search Constraints

You searched for: Author/Creator Ito, Masaoki

Search Results

1. Characterising acquired resistance to erlotinib in non-small cell lung cancer patients. (3rd October 2019)

2. Clinicopathologic Features and Response to Therapy of NRG1 Fusion–Driven Lung Cancers: The eNRGy1 Global Multicenter Registry. Issue 25 (1st September 2021)

3. Different significance of HRCT and FDG-PET/CT to predict lymph node status between patients with clinical stage IA lung adenocarcinoma and squamous cell carcinoma. Issue 1 (December 2015)

4. Digital multiplexed analysis of circular RNAs in FFPE and fresh non‐small cell lung cancer specimens. Issue 12 (10th February 2022)

5. Impact of the amount of preoperative erector spinae muscle in stage I non-small-cell lung cancer. (31st October 2022)

9. Pathological high malignant grade is higher risk of recurrence in pN0M0 invasive lung adenocarcinoma, even with small invasive size. Issue 23 (12th October 2021)

10. Positive EGFR mutation status is a risk of recurrence in pN0–1 lung adenocarcinoma when combined with pathological stage and histological subtype: A retrospective multi-center analysis. (March 2020)